Ronna Hauser, PharmD, Senior Vice President of Policy & Pharmacy Affairs at NCPA, provides insights into President Trump’s most recent executive order regarding manufacturer drug prices.
Ronna Hauser, PharmD
Advertisement
Articles by Ronna Hauser, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
